Reference
Hsu P-C, et al. Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan. Targeted Oncology 18: 195-207, 20 Feb 2023. Available from: URL: http://doi.org/10.1007/s11523-023-00946-w
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1986, 25 (2023). https://doi.org/10.1007/s40278-023-51330-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-51330-6